{"id":45396,"date":"2026-02-06T10:54:15","date_gmt":"2026-02-06T09:54:15","guid":{"rendered":"https:\/\/swedenbio.se\/?post_type=medlemmar&#038;p=45396"},"modified":"2026-02-25T10:42:03","modified_gmt":"2026-02-25T09:42:03","slug":"cyclic-therapeutics","status":"publish","type":"medlemmar","link":"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/","title":{"rendered":"Cyclic Therapeutics"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Its proprietary platforms, EvoBind\u00a0and RareFold, enable blind de novo design of linear and cyclic peptides directly from protein sequence, without requiring target structures, binding sites, or predefined peptide lengths. The models incorporate induced fit and directed evolution in silico and expand the design space beyond the 20 natural amino acids through non-canonical residues. The platform has been experimentally validated across multiple case studies, including high-affinity peptide binders, the first blind sequence-only design of cyclic GPCR agonists, and single-round design of an antiviral cyclic peptide inhibitor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Its proprietary platforms, EvoBind\u00a0and RareFold, enable blind de novo design of linear and cyclic peptides directly from protein sequence, without requiring target structures, binding sites, or predefined peptide lengths. The models incorporate induced fit and directed evolution in silico and expand the design space beyond the 20 natural amino acids through non-canonical residues. The platform [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"user_categories":[7,44],"class_list":["post-45396","medlemmar","type-medlemmar","status-publish","hentry","user_categories-biotech","user_categories-life-science-companies"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cyclic Therapeutics - SwedenBIO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cyclic Therapeutics - SwedenBIO\" \/>\n<meta property=\"og:description\" content=\"Its proprietary platforms, EvoBind\u00a0and RareFold, enable blind de novo design of linear and cyclic peptides directly from protein sequence, without requiring target structures, binding sites, or predefined peptide lengths. The models incorporate induced fit and directed evolution in silico and expand the design space beyond the 20 natural amino acids through non-canonical residues. The platform [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"SwedenBIO\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T09:42:03+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/medlemmar\\\/cyclic-therapeutics\\\/\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/medlemmar\\\/cyclic-therapeutics\\\/\",\"name\":\"Cyclic Therapeutics - SwedenBIO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#website\"},\"datePublished\":\"2026-02-06T09:54:15+00:00\",\"dateModified\":\"2026-02-25T09:42:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/medlemmar\\\/cyclic-therapeutics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/swedenbio.se\\\/en\\\/medlemmar\\\/cyclic-therapeutics\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/medlemmar\\\/cyclic-therapeutics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cyclic Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\",\"name\":\"SwedenBIO\",\"description\":\"Branschorganisationen f\u00f6r svenska life science f\u00f6retag\",\"publisher\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#organization\",\"name\":\"SwedenBIO\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/logo.png\",\"width\":240,\"height\":59,\"caption\":\"SwedenBIO\"},\"image\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cyclic Therapeutics - SwedenBIO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"Cyclic Therapeutics - SwedenBIO","og_description":"Its proprietary platforms, EvoBind\u00a0and RareFold, enable blind de novo design of linear and cyclic peptides directly from protein sequence, without requiring target structures, binding sites, or predefined peptide lengths. The models incorporate induced fit and directed evolution in silico and expand the design space beyond the 20 natural amino acids through non-canonical residues. The platform [&hellip;]","og_url":"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/","og_site_name":"SwedenBIO","article_modified_time":"2026-02-25T09:42:03+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/","url":"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/","name":"Cyclic Therapeutics - SwedenBIO","isPartOf":{"@id":"https:\/\/swedenbio.se\/en\/#website"},"datePublished":"2026-02-06T09:54:15+00:00","dateModified":"2026-02-25T09:42:03+00:00","breadcrumb":{"@id":"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/swedenbio.se\/en\/"},{"@type":"ListItem","position":2,"name":"Cyclic Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/swedenbio.se\/en\/#website","url":"https:\/\/swedenbio.se\/en\/","name":"SwedenBIO","description":"Branschorganisationen f\u00f6r svenska life science f\u00f6retag","publisher":{"@id":"https:\/\/swedenbio.se\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/swedenbio.se\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/swedenbio.se\/en\/#organization","name":"SwedenBIO","url":"https:\/\/swedenbio.se\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/swedenbio.se\/en\/#\/schema\/logo\/image\/","url":"https:\/\/swedenbio.se\/wp-content\/uploads\/2020\/09\/logo.png","contentUrl":"https:\/\/swedenbio.se\/wp-content\/uploads\/2020\/09\/logo.png","width":240,"height":59,"caption":"SwedenBIO"},"image":{"@id":"https:\/\/swedenbio.se\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/medlemmar\/45396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/medlemmar"}],"about":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/types\/medlemmar"}],"author":[{"embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/comments?post=45396"}],"version-history":[{"count":3,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/medlemmar\/45396\/revisions"}],"predecessor-version":[{"id":45533,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/medlemmar\/45396\/revisions\/45533"}],"wp:attachment":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/media?parent=45396"}],"wp:term":[{"taxonomy":"user_categories","embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/user_categories?post=45396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}